These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


211 related items for PubMed ID: 4275415

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Cleavage of blood coagulation factor XIII and fibrinogen by thrombin during in vitro clotting.
    Greenberg CS, Miraglia CC, Rickles FR, Shuman MA.
    J Clin Invest; 1985 May; 75(5):1463-70. PubMed ID: 2860124
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Cross-linking of salmon fibrinogen and fibrin by factor XIII and transglutaminase.
    Murtaugh PA, Halver JE, Gladner JA.
    Biochem Biophys Res Commun; 1973 Oct 01; 54(3):849-55. PubMed ID: 4148128
    [No Abstract] [Full Text] [Related]

  • 27. Effect of cysteine and hemolyzed erythrocytes on the properties of clotted fibrin.
    Ostrowski L.
    Pol Med J; 1966 Oct 01; 5(6):1197-214. PubMed ID: 5973024
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Modern data on the chemistry and physiology of fibrinogen].
    Andreenko GV.
    Usp Sovrem Biol; 1974 Oct 01; 77(1):51-69. PubMed ID: 4282801
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Postsurgical hemorrhage in dogs anticoagulated with ancrod (Arvin).
    Slade CL, Taylor LM, Wechsler AS, McKee PA.
    Ann Surg; 1973 Dec 01; 178(6):721-6. PubMed ID: 4759405
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Inhibition of the platelet-dependent fibrin retraction by the fibrin stabilizing factor (FSF, factor 13).
    Niewiarowski S, Markiewicz M, Nath N.
    J Lab Clin Med; 1973 May 01; 81(5):641-50. PubMed ID: 4698655
    [No Abstract] [Full Text] [Related]

  • 35. Fibrinogen turnover and drugs acting on fibrinolysis.
    De Nicola P.
    Acta Univ Carol Med Monogr; 1972 May 01; 52():25-31. PubMed ID: 4544612
    [No Abstract] [Full Text] [Related]

  • 36. Degradation of fibrinogen by plasmin: biological effects of the non-dialysable fibrinogen derivatives.
    Triantaphyllopoulos DC, Chandra S.
    Thromb Diath Haemorrh Suppl; 1973 May 01; 56():113-26. PubMed ID: 4281938
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. The hematologic consequences of thrombolytic therapy.
    Fletcher AP, Alkjaersig NK.
    Prog Hematol; 1986 May 01; 14():183-200. PubMed ID: 2935903
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 11.